Your session is about to expire
← Back to Search
Radiation Therapy
Yttrium-90 Radiation Segmentectomy for Liver Cancer (SBRT vs Y90 Trial)
N/A
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 months for the first subject and 4 months for the second
Awards & highlights
SBRT vs Y90 Trial Summary
This trial will compare the effects of two different types of radiation therapy on early stage liver cancer.
Eligible Conditions
- Liver Cancer
SBRT vs Y90 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 months for the first subject and 4 months for the second
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 months for the first subject and 4 months for the second
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of Recruitment (Recruitment Rate)
Secondary outcome measures
Disease-free Survival (DFS) Rates of RS and SBRT
Mean Change in Comprehensive Score for Financial Toxicity
Mean Change in Functional Assessment of Cancer Therapy- General (FACT-G) Score
+4 moreSBRT vs Y90 Trial Design
2Treatment groups
Active Control
Group I: Yttrium-90 Radiation SegmentectomyActive Control1 Intervention
Group II: Stereotactic Body Radiation TherapyActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
993 Previous Clinical Trials
1,095,281 Total Patients Enrolled
2 Trials studying Liver Cancer
35 Patients Enrolled for Liver Cancer
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger